Five biotransformation products, mefenamic acid-7-O-β-D-glucopyranosyl ester (2) (5), and mefenamic acid-7-O-α-D-(β-1,6-O-Dglucopyranosyl)-2-glucopyranose ester (6) were isolated from cell suspension cultures of Solanum mammosum following administration of the therapeutic agent mefenamic acid (1). The structures of all new compounds were elucidated on the basis of their NMR and mass spectrometric data.
Cell cultures of higher plants are potential biocatalysts for the production of novel substances for use in either organic synthesis or industrial processes since they convert common organic substances into functionalized, and therefore valueadded, materials. The reaction types involved in biotransformation of exogenous substrates include hydroxylation, oxidation, reduction of carbonyl or alkene functionality, hydrolysis, and glycosyl conjugation [1] . The last biotransformation is of interest because of the difficulty to perform this reaction by either chemical synthesis or by microbiological bioconversion [2] , and the products are usually water-soluble, while the glycosyl moiety may subsequently be removed by hydrolysis. Consequently, the glycosylated products of waterinsoluble therapeutic agents may have potential as pro-drugs [3] .
Mefenamic acid is used as a non-steroidal antiinflammatory drug for treatment of pain, but has been linked to acute renal failure and nephritis. In the body, mefenamic acid can be glucuronidated [4, 5] , and the acyl glucuronide products have been assessed for stability and ability to bind irreversibly to proteins [5] . In this paper, we assess the conversion of mefenamic acid into glucosylated products by cell suspensions of Solanum mammosum. In earlier work, it has been shown that this plant cell culture converts salicyl alcohol into the glucopyranoside salicin, and salicylamide into salicylamide 2-O-β-D-glucopyranoside [6, 7] . o-Aminobenzoic acid was converted by this same suspension culture into o-aminobenzoic acid 7-O-β-D-glucopyranosyl ester and o-aminobenzoic acid 7-O-β-D-(β-1,6-O-D-glucopyranosyl)-glucopyranosyl ester, while p-aminobenzoic acid was converted into p-amino benzoic acid 7-O-β-D-glucopyranosyl ester, together with N-acetyl p-amino benzoic acid and N-formyl p-amino benzoic acid [8, 9] . Cell suspension cultures of S. mammosum also biotransformed resorcinol into resorcinol-O-β-D-glucopyranoside and hydroquinone into arbutin [10] .
The toxicity of mefenamic acid (1) toward cell suspension cultures of S. mammosum was investigated over a concentration range of 25-700 mg/L. Cell death occurred at concentrations > 150 mg/L. At a concentration of 100 mg/L, the cells survived, their colors remained green, while their growth indices (0.70) and packed cell volumes (57%) were reduced compared to cultures without administration of the substrate (1.40 and 92% respectively). This substrate concentration was selected for biotransformation experiments. Control experiment showed that in the absence of cells, the mefenamic acid substrate remained unchanged in the culture medium, while the new metabolites 2-6 were only produced in the presence of cell cultures of S. mammosum.
Incubation of a cell suspension culture, prepared as described previously [8] , with mefenamic acid followed by methanol extraction and purification by various chromatographic methods gave the monoglucoside 2, two diglucosides 3 and 4, and a mixture of the two stereoisomeric diglucosides 5 and 6. The structures of the biotransformation products were elucidated on the basis of their NMR and MS data, and by comparison with data for 1 ( Tables 1 and  2 ). An earlier 1 H NMR spectroscopic analysis of mefenamic acid by McGurk et al. [5] assigned the signals of H-3 and H-6′ differently from our investigation. The 13 C data shown for 1 are in accordance with data published by Sato et al. [4] .
Metabolite 2 exhibited a pseudomolecular ion at m/z 426.1523 [M+Na] + for the molecular formula C 21 H 25 NO 7 , corresponding to a monoglycosyl analogue of mefenamic acid. The sugar was identified as glucose by careful analysis of 1 H coupling constants, DQFCOSY and HSQC data, and by comparison with NMR data of the glucopyranoside ester transformation products of o-aminobenzoic acid [8] and 2-phenylpropionic acid [11, 12] . The downfield shift of H-1″ (δ 5.76), and of C-1″ (95.6 ppm), together with the HMBC correlation between H-1″ and the ester carbon at 168.2 ppm confirmed the point of attachment of the sugar unit. A β-orientation of the glucoside linkage was demonstrated by the coupling of 8.0 Hz between H-1″ and H-2″. Thus, the metabolite 2 was mefenamic acid-7-O-β-D-glucopyranosyl ester.
For metabolite 3, a pseudomolecular ion at m/z 588.2053 [M+Na] + established a molecular formula of C 27 H 35 NO 12 . The 13 C spectrum revealed twelve oxygenated carbons in addition to signals for the mefenamic acid moiety. Thus the compound contained two hexose sugar units, and was confirmed as a diglucoside by comparison of chemical shift data with that for diglucopyranoside esters formed by biotransformation of o-and p-aminobenzoic acids [8, 9] . Since there was considerable signal overlap in the proton spectrum of 3, analysis of TOCSY data was helpful in distinguishing the individual proton signals of the two sugars. In the 1 H NMR spectrum of 3, doublet signals at δ 5.74 (J = 7.7 Hz) and 4.33 (J = 7.8 Hz) indicated the presence of two β-glucose moieties [8, 9] . The downfield shift of the inner C-6″(69.2 ppm) compared to C-6′′′ (62.3 ppm) of the outer ring, suggested glycosylation at C-6″ [8, 11] . The HMBC spectrum showed correlations from the inner anomeric proton, H-1″ at δ 5.74, to a carbonyl group at 168.2 ppm (C-7), and from δ 4.33, assigned to the anomeric proton H-1′′′ of the outer glucose, to C-6″. These data showed that this product was mefenamic acid-7-β-D-(β-1,6-O-D-glucopyranosyl)glucopyranosyl ester. [13] . The facile hydrolysis of acyl glucosides and glucuronides is well documented [5, 14] .
The anomeric components 5 and 6 were isolated as a mixture, in trace quantity, by reverse phase HPLC. HRMS data could not be obtained, but LR-MS measurements showed a nominal mass of m/z 566 corresponding to diglucoside metabolites. For each component of the mixture, the two sets of sugar protons were again identified by TOCSY data, and linked to their respective carbons by HSQC data. The chemical shift values again suggested both sugars were glucose. In the 1 H NMR spectrum of the mixture, acetal protons for H-1″ at δ 4.81 (J = 8.0 Hz) and at δ 5.41 (J = 3.7 Hz) clearly established β and α configurations for the anomeric centers of the inner sugar of 5 and 6, respectively. In each component (5 and 6) , the chemical shift values for the inner anomeric proton were shifted upfield relative to the corresponding values in metabolites 2-4, whereas the inner H-2″ signals were shifted downfield (δ 4.97 in 5; δ 4.88 in 6) compared to products 2-4 [11, 12] . These data indicated that the mefenamic acid moiety was attached to the inner sugar at the C-2″ position. HMBC data (750 MHz) showed that in each anomer H-2″ was correlated to C-7 of the mefenamic acid, as well as to C-1″ and C-3″. The two sugars were again 1,6-linked since H-6″ correlated to C-1′′′, while H-1′′′ correlated to C-6′′, as well as to C-2′′′. Owing to the small sample size, it was not possible to obtain either satisfactory NOESY or 1D nOe information. The data identified metabolites 5 and 6 as mefenamic acid-7-O-β-D-(β-1,6-O-D-glucopyranosyl)-2-glucopyranose ester (5) and mefenamic acid-7-O-α-D-(β-1,6-O-Dglucopyranosyl)-2-glucopyranose ester (6) .
The initially produced monoglucoside 2 may be glucosylated at either C-6 or C-2 of the glucose moiety, giving 3 or 4, respectively. Acyl migration from diglucoside product 3 may provide the 2-O-glucosylated product mixture 5/6 [5, 11, 12] . As far as can be ascertained, our study represents the first report of biotransformation of mefenamic acid by a plant cell suspension culture. None of these glucopyranosyl ester products have been previously reported from natural sources. Consequently, biocatalyzed transformation of mefenamic acid by plant suspension cultures has potential to provide a synthetic route to pro-drug forms of this non-steroidal anti-inflammatory and analgesic agent.
Experimental
General: The NMR spectroscopic data of 1 were measured on a Bruker Avance 400 MHz spectrometer in MeOH-d 4 at 298K. The NMR spectroscopic data of 2-6 were recorded on either a Bruker Avance 500 MHz or 750 MHz spectrometer in MeOH-d 4 at 298K using a 5 mm inverse probe. Gradient selection was applied for HMBC and HSQC experiments. TOCSY data (mixing time of 60 msec) were determined in phase sensitive mode. For both HSQC and HMBC spectra, the data were acquired using a 1 J C-H of 135 Hz, while HMBC spectra were acquired using n J C-H of 4, 6 or 8 Hz. Positive ion electrospray mass spectra (LRESMS) were determined using a Bruker Esquire HCT instrument or (HRESMS) using a MicroTof Q instrument each with a standard ESI source. Samples were introduced into the source using MeOH as solvent. Reverse phase HPLC was carried out on an Agilent 1100 series instrument fitted with a Waters HPLC column Bondapak C 18 (300 x 7.8 mm i.d., 10 μ) and UV detection at 254 nm. Silica gel 60 G and precoated silica TLC plates F 254 were purchased from Merck. A Shimadzu CS 930 TLC Scanner was used to measure the in situ UV absorbance reflectance spectra of the chromatogram spots. All solvents were either distilled or were of HPLC grade.
Cell suspension culture and biotransformation conditions:
Cell suspension cultures were initiated from callus cultures of Solanum mammosum. The calli were cultivated in 300 mL Erlenmeyer flasks containing 50 mL of modified Murashige and Skoog medium [15] supplemented with 30 g/L sucrose
